Form 8.3 Life Science REIT Plc

Key Information - Rathbones Group Plc has disclosed a position in Life Science REIT Plc, holding 9,391,953 relevant securities, which represents 2.68% of the total [1][3] - The position was disclosed as of February 27, 2026, and the disclosure includes interests in other parties to the offer [1][1] Positions of the Discloser - The disclosed interests consist solely of 9,391,953 ordinary shares, with no short positions reported [3] - The total percentage of relevant securities owned and/or controlled is 2.68% [3] Dealings - Rathbones Group Plc sold a total of 39,000 ordinary shares, with individual sales of 24,000 shares at 42.6p and 15,000 shares at 42.5081p [7] Other Information - There are no indemnity or other dealing arrangements related to the relevant securities [12] - No agreements or understandings regarding options or derivatives were reported [13]